154 related articles for article (PubMed ID: 33397352)
1. History of lower-limb complications and risk of cancer death in people with type 2 diabetes.
Mohammedi K; Harrap S; Mancia G; Marre M; Poulter N; Chalmers J; Woodward M
Cardiovasc Diabetol; 2021 Jan; 20(1):3. PubMed ID: 33397352
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
[TBL] [Abstract][Full Text] [Related]
3. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial.
Low Wang CC; Blomster JI; Heizer G; Berger JS; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Lopes RD; Olin JW; Rockhold FW; Mahaffey KW; Patel MR; Hiatt WR;
J Am Coll Cardiol; 2018 Dec; 72(25):3274-3284. PubMed ID: 30573030
[TBL] [Abstract][Full Text] [Related]
5. Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Melo JV; Santos TRM; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Feb; 20(1):54. PubMed ID: 33639945
[TBL] [Abstract][Full Text] [Related]
6. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
Anand SS; Caron F; Eikelboom JW; Bosch J; Dyal L; Aboyans V; Abola MT; Branch KRH; Keltai K; Bhatt DL; Verhamme P; Fox KAA; Cook-Bruns N; Lanius V; Connolly SJ; Yusuf S
J Am Coll Cardiol; 2018 May; 71(20):2306-2315. PubMed ID: 29540326
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.
Mueller T; Hinterreiter F; Poelz W; Haltmayer M; Dieplinger B
Vasc Med; 2016 Oct; 21(5):445-452. PubMed ID: 27067137
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial.
Badjatiya A; Merrill P; Buse JB; Goodman SG; Katona B; Iqbal N; Pagidipati NJ; Sattar N; Holman RR; Hernandez AF; Mentz RJ; Patel MR; Jones WS
Circ Cardiovasc Interv; 2019 Dec; 12(12):e008018. PubMed ID: 31752517
[TBL] [Abstract][Full Text] [Related]
9. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
Malmstedt J; Kärvestedt L; Swedenborg J; Brismar K
Cardiovasc Diabetol; 2015 Jul; 14():93. PubMed ID: 26216409
[TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
[TBL] [Abstract][Full Text] [Related]
11. Risk and Prognosis of Cancer After Lower Limb Arterial Thrombosis.
Sundbøll J; Veres K; Horváth-Puhó E; Adelborg K; Sørensen HT
Circulation; 2018 Aug; 138(7):669-677. PubMed ID: 29540440
[TBL] [Abstract][Full Text] [Related]
12. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study.
Biscetti F; Nardella E; Rando MM; Cecchini AL; Angelini F; Cina A; Iezzi R; Filipponi M; Santoliquido A; Pitocco D; Landolfi R; Flex A
Cardiovasc Diabetol; 2020 Oct; 19(1):170. PubMed ID: 33028322
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study.
Avdic T; Carlsen HK; Rawshani A; Gudbjörnsdottir S; Mandalenakis Z; Eliasson B
Cardiovasc Diabetol; 2024 Apr; 23(1):127. PubMed ID: 38622586
[TBL] [Abstract][Full Text] [Related]
14. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
[TBL] [Abstract][Full Text] [Related]
15. Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients.
Lin TY; Chou HH; Huang HL; Hung SC
Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33147880
[TBL] [Abstract][Full Text] [Related]
16. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
[TBL] [Abstract][Full Text] [Related]
17. Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Williams B; Lisheng L; Rodgers A; Mancia G; Neal B; Harrap S; Marre M; Chalmers J;
Diabetes Care; 2016 Oct; 39(10):1796-803. PubMed ID: 27456835
[TBL] [Abstract][Full Text] [Related]
18. Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease.
Haine A; Kavanagh S; Berger JS; Hess CN; Norgren L; Fowkes FGR; Katona BG; Mahaffey KW; Blomster JI; Patel MR; Jones WS; Rockhold FW; Hiatt WR; Baumgartner I;
J Am Coll Cardiol; 2020 Feb; 75(6):608-617. PubMed ID: 32057375
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery disease.
McDermott MM; Tian L; Wunderink RG; Kalhan R; Kibbe MR; Greenland P; Tracy R; Zhao L; Liu K; Huffman M; Wilkins JT; Liao Y; Shah S; Lloyd Jones D; Green D
Vasc Med; 2017 Jun; 22(3):218-224. PubMed ID: 28466756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
